Answers are grounded in this paper and cite their sources.
High-grade serous ovarian carcinoma (HGSOC) lacks biomimetic 3D models that accurately replicate the native extracellular matrix (ECM) microenvironment. Here, we developed a novel tissue-specific ovarian cancer hydrogel (OCH) derived from human HGSOC surgical specimens via an optimized detergent-enzymatic treatment and self-assembly workflow. Quantitative analysis demonstrated effective decellularization with a 98.8% reduction in DNA content while preserving essential structural ECM components, including laminin, collagen I and collagen IV. Second harmonic generation (SHG) and scanning electron microscopy (SEM) confirmed the preservation of an isotropic, highly porous fibrillar collagen architecture. The resulting 3% (w/v) OCH undergoes rapid thermal gelation under physiological conditions (t1/2 = 6.2 min), exhibiting a high swelling capacity, homogeneous molecular transport properties (spatially uniform dextran diffusion), and local mechanical stiffness comparable to a commercial hydrogel. Encapsulated OVCAR3 cells established intimate cell–ECM interactions and exhibited high cytocompatibility alongside sustained long-term proliferation (74.8% of Ki67+ cells). Notably, OVCAR3 cells cultured within the OCH exhibited significantly reduced sensitivity to doxorubicin compared with those cultured in a commercially available hydrogel, highlighting the potential contribution of the patient-derived tumor extracellular matrix to chemotherapy resistance. Overall, OCHs provide a human tumor-derived, tissue-specific 3D model of ovarian cancer, representing a promising organotypic platform for drug screening and translational cancer research.
No takes yet. Share an insight, caveat, or question.
Sensi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: